Vaccines in 2017: Closing in on a Zika virus vaccine

Nature Reviews Immunology 18, 89 (2018). doi:10.1038/nri.2017.132 Authors: Michael S. Diamond & Carolyn B. Coyne Over the past 2 years, Zika virus (ZIKV) has emerged as a pathogen capable of causing devastating congenital malformations in the developing fetus and significant neurological disease in adults. In 2017, substantial progress has been made towards the development, immunological analysis and preclinical evaluation of vaccine platforms to prevent the pathologies associated with ZIKV infection.
Source: Nature Reviews Immunology - Category: Allergy & Immunology Authors: Tags: Year in Review Source Type: research